Illumina said today it is partnering with the Hartwell Autism Research and Technology Initiative (iHART) to establish a genomic database for autism spectrum disorder (ASD). The effort is part of iHART’s mission to establish the largest shared, open-access repository of bioinformatic data on autism.
In addition to providing insights into ASD, the collaboration aims to develop a user-friendly interface that will be accessible to researchers as well as individuals outside the research community, including families participating in the study.
